Jonathan Yong
Stock Analyst at UBS
(2.64)
# 2,019
Out of 5,112 analysts
96
Total ratings
61.11%
Success rate
11.48%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Sell | $11 → $12 | $15.31 | -21.62% | 9 | Nov 7, 2025 | |
| EHTH eHealth | Maintains: Neutral | $7 → $5 | $5.11 | -2.15% | 6 | Aug 7, 2025 | |
| CLOV Clover Health Investments | Maintains: Neutral | $4.5 → $3 | $2.63 | +14.29% | 4 | Aug 6, 2025 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $9.69 | +23.84% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $2.77 | +188.81% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $8.09 | +221.58% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $35.42 | -60.47% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $76.90 | +24.84% | 3 | Aug 8, 2023 | |
| SEM Select Medical Holdings | Maintains: Neutral | $29 → $32 | $14.92 | +114.48% | 3 | Aug 7, 2023 | |
| AMN AMN Healthcare Services | Maintains: Outperform | $115 → $105 | $16.41 | +540.05% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $107.85 | -25.82% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $253.54 | -8.89% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $7.35 | +267.35% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $200.31 | -50.08% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $817.36 | -44.94% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $2.35 | +410.64% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $4.74 | +1,376.79% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $19.29 | -11.87% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $163.61 | +113.92% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $14.24 | +567.37% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $2.60 | +226.92% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $23.94 | +71.26% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $3.25 | +423.08% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.28 | +159.15% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $79.08 | +7.49% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $177.02 | -17.52% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $39.77 | +166.53% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $227.87 | -31.10% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $273.20 | +34.70% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $266.32 | +138.43% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $78.02 | +49.96% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $21.72 | +38.12% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $472.34 | -36.91% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $196.85 | -51.74% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $329.14 | +50.39% | 1 | Oct 15, 2021 |
Oscar Health
Nov 7, 2025
Maintains: Sell
Price Target: $11 → $12
Current: $15.31
Upside: -21.62%
eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $5.11
Upside: -2.15%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5 → $3
Current: $2.63
Upside: +14.29%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $9.69
Upside: +23.84%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $2.77
Upside: +188.81%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $8.09
Upside: +221.58%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $35.42
Upside: -60.47%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $76.90
Upside: +24.84%
Select Medical Holdings
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $14.92
Upside: +114.48%
AMN Healthcare Services
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $16.41
Upside: +540.05%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $107.85
Upside: -25.82%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $253.54
Upside: -8.89%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $7.35
Upside: +267.35%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $200.31
Upside: -50.08%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $817.36
Upside: -44.94%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $2.35
Upside: +410.64%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $4.74
Upside: +1,376.79%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $19.29
Upside: -11.87%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $163.61
Upside: +113.92%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $14.24
Upside: +567.37%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $2.60
Upside: +226.92%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $23.94
Upside: +71.26%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $3.25
Upside: +423.08%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.28
Upside: +159.15%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $79.08
Upside: +7.49%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $177.02
Upside: -17.52%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $39.77
Upside: +166.53%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $227.87
Upside: -31.10%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $273.20
Upside: +34.70%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $266.32
Upside: +138.43%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $78.02
Upside: +49.96%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $21.72
Upside: +38.12%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $472.34
Upside: -36.91%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $196.85
Upside: -51.74%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $329.14
Upside: +50.39%